farxiga glp 1 New GLP-1 Guidelines for Type 2 Diabetes in 2025 GLP-1 Drugs and Type 1

Stanford Medicine psychiatrist Anna Lembke unpacks the potential of FDA-approved weight-reducing GLP-1 drugs like Ozempic as tools in treating addiction.

22, 2025 (GLOBE NEWSWIRE) -- Disclaimer: This article is for informational purposes only and does not constitute medical advice

Eric Topol: GLP-1 Drugs Reduce Substance Abuse Risk in Over 600,000 US Veterans / cancer, Eric Topol, GLP-1, OncoDaily, Oncology

Blue Cross Blue Shield may cover Mounjaro for Type 2 diabetes with prior authorization but not necessarily for weight loss.

The responsible message: Substantial weight loss usually includes some loss of lean tissue

The impact of antidiabetic drugs on bone metabolism is drawing increasing attention due to the discovery of a correlation between type 2 diabetes mellitus an...